Michael Aaron Kelly Aprea Therapeutics, Inc. (APRE) insider trading activity

Michael Aaron Kelly is Director of Aprea Therapeutics, Inc.. Currently has a direct ownership of 4,610 shares of APRE, which is worth approximately $18,901. The most recent transaction as insider was on Jun 30, 2021, when has been sold 4,610 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.61K

0% 3M change

0% 12M change

Total Value Held $18,901

Michael Aaron Kelly Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 30 2021	BUY Grant, award, or other acquisition	-	4,610 Added 50.0%	4,610 Common Stock

Also insider at

FOLD

AMICUS THERAPEUTICS, INC. Healthcare

NEO

NEOGENOMICS INC Healthcare

Director

BOOM

DMC Global Inc. Energy

Director

HOOK

HOOKIPA Pharma Inc. Healthcare

Director

PRME

Prime Medicine, Inc.

Director

MAK